Pharmaceutical quality control in India plays an important role in maintaining the quality, consistency, and reliability of medicines. Every medicine must meet its approved specifications and applicable quality requirements before it can be released for sale or supply.

Quality control is not limited to testing the finished medicine in a laboratory. It involves checking incoming raw materials, verifying manufacturing processes, inspecting packaging materials, reviewing batch records, investigating deviations, and confirming that the required quality checks have been completed.

For pharmaceutical companies, manufacturers, distributors, and pharmaceutical franchise businesses, understanding these processes can support better purchasing decisions and stronger quality-management practices.

Ernst Pharmacia operates in the Indian pharmaceutical sector and provides pharmaceutical product and third-party manufacturing-related services. Businesses evaluating any Pharmaceutical company should review its relevant licences, product documentation, manufacturing arrangements, and quality requirements before entering into a commercial agreement.

What Is Pharmaceutical Quality Control?

Pharmaceutical quality control (QC) is the part of a pharmaceutical quality system concerned with sampling, specifications, testing, documentation, and procedures for approving or rejecting materials and products.

Its purpose is to determine whether materials and medicines meet their established acceptance criteria.

Quality control activities may include:

• Testing raw materials before they are used in production.
• Inspecting packaging materials and labels.
• Checking samples collected during manufacturing.
• Testing finished products against approved specifications.
• Reviewing laboratory results and associated records.
• Investigating results that do not meet specifications.
• Supporting decisions to release or reject a batch.

The exact tests depend on the product, dosage form, approved specifications, applicable pharmacopoeial requirements, and relevant regulatory provisions.

The World Health Organization explains that Good Manufacturing Practices (GMP) cover both production and quality control to help ensure that medicines are consistently manufactured and controlled to the required quality standards.

Why Is Quality Control Important in the Pharmaceutical Industry?

Medicine quality can be affected by many factors, including raw material variability, contamination, manufacturing errors, unsuitable storage conditions, and incorrect labelling.

A well-designed quality system helps identify and control these risks.

1. Consistent product quality

Each manufactured batch must be evaluated against its relevant specifications. Consistent processes and appropriate testing help identify variations that could affect the final product.

2. Patient safety

Quality systems help reduce the risk of contamination, incorrect ingredient quantities, unsuitable packaging, and labelling errors. Laboratory testing alone cannot prevent every manufacturing problem, which is why quality must be built into the complete production process.

3. Regulatory compliance

Pharmaceutical manufacturers must comply with the applicable Indian regulatory framework, including relevant provisions of the Drugs and Cosmetics Act and Rules, licensing conditions, and GMP requirements.

4. Reliable business relationships

Distributors, hospitals, pharmacies, and pharmaceutical franchise businesses need confidence that products are supplied through appropriate quality and documentation systems. Reviewing a supplier’s quality processes can help businesses make more informed decisions.

Key Stages of Pharmaceutical Quality Control

Quality checks are performed at different stages of the product lifecycle. The following are common examples; the actual control plan depends on the product and applicable requirements.

1. Raw material testing

Raw materials may include active pharmaceutical ingredients (APIs), excipients, solvents, and other substances used in manufacturing.

Before materials are approved for use, the responsible quality team follows established procedures for sampling, testing, documentation, and material status control.

Common checks may include:

• Identity testing.
• Assay or content testing, where applicable.
• Purity and impurity testing.
• Physical and chemical characteristics.
• Microbiological testing, where required.
• Verification of supplier documents and material specifications.

Materials that have not been appropriately assessed should not be treated as approved for production. Acceptance criteria and testing requirements must be established for the specific material.

2. In-process quality control

In-process checks take place while a medicine is being manufactured. They help verify that important process parameters remain within established limits.

Depending on the dosage form, checks may include:

• Tablet weight variation and physical characteristics.
• Capsule fill weight and appearance.
• Mixing uniformity or blend uniformity, where applicable.
• pH, viscosity, or fill volume for suitable liquid products.
• Temperature, time, and other critical process parameters.
• Environmental or equipment checks where required.

In-process testing does not replace finished-product testing. It is one part of an overall quality-control strategy.

3. Finished product testing

After manufacturing, representative samples of the finished product are tested against approved specifications.

Testing depends on the formulation, product category, and applicable standards. Examples include:

Dosage form	Examples of quality checks
Tablets	Appearance, identification, assay, dissolution and uniformity tests as applicable
Capsules	Appearance, fill or content checks, assay and dissolution where applicable
Oral liquids and syrups	Appearance, identification, assay, pH, microbial quality and other applicable tests
Ointments and creams	Appearance, homogeneity, assay, viscosity or other specified tests
Sterile products and injectables	Sterility, endotoxins, particulate matter, assay and other applicable tests
Eye drops	Relevant sterility, particulate, assay and packaging requirements, as applicable

This table gives examples, not a universal testing checklist. Not every test applies to every product. Testing must follow the product’s approved specifications and relevant requirements.

4. Packaging material inspection

Packaging helps protect medicines from physical damage, moisture, light, contamination, and other environmental factors when the packaging system is appropriately selected and validated.

Quality teams may verify:

• Material identity and approved specifications.
• Container and closure suitability.
• Printed information and label correctness.
• Batch number and expiry-date printing.
• Packaging integrity and seal quality.
• Compatibility with the medicine, where relevant.
• Reconciliation and control of printed packaging materials.

Correct labelling is especially important because packaging errors can lead to product identification mistakes.

Pharmaceutical Quality Control vs Quality Assurance

Quality control and quality assurance are related, but they are not identical.

Quality Control (QC)	Quality Assurance (QA)
Focuses on sampling, inspection, testing and results	Focuses on the overall system used to achieve and maintain quality
Evaluates whether materials and products meet specifications	Helps ensure that approved processes and procedures are followed
Reviews laboratory data and test outcomes	Reviews procedures, records, deviations, audits and quality-system performance
Provides information for acceptance or rejection decisions	Supports oversight of batch documentation and authorised release processes

A strong pharmaceutical quality system requires both. Passing a laboratory test does not automatically demonstrate that every manufacturing and documentation requirement has been met.

What Is Pharmaceutical Batch Release?

Batch release is the controlled process through which an authorised person or responsible quality function determines whether a particular batch meets the applicable requirements for release.

A batch should not be released merely because production is complete or because one laboratory test has passed.

Before release, the responsible personnel typically review the relevant production records, laboratory results, packaging and labelling records, and any deviations or investigations that could affect product quality.

Common steps in batch release

Step 1: Review manufacturing records

Check whether the batch was manufactured according to approved procedures and whether required entries, signatures, and process checks are complete.

Step 2: Review laboratory results

Confirm that required tests have been performed, results have been reviewed, and the batch meets the applicable acceptance criteria.

Step 3: Review packaging and labelling

Verify the relevant packaging records and confirm that the product identity, batch details, and required label information are correct.

Step 4: Investigate deviations

Any relevant deviation, unexpected result, or out-of-specification result must be assessed and documented through the applicable procedure. It should not be ignored or simply repeated until a passing result appears.

Step 5: Confirm documentation is complete

Check that required records, reviews, and approvals are available and traceable.

Step 6: Make the authorised decision

The designated authorised personnel determine whether the batch can be released or must remain on hold, undergo further investigation, or be rejected.

The precise approval responsibilities and requirements depend on the applicable Indian rules, product category, licence conditions, and manufacturing arrangement.

Essential Pharmaceutical Quality Documents

Documentation provides evidence that materials, processes, tests, and decisions have been managed according to approved procedures.

Depending on the product and applicable requirements, important records may include:

1. Certificate of Analysis (CoA)

A Certificate of Analysis reports specified test results for a material or product against defined acceptance criteria. Buyers should confirm that the document relates to the correct product, batch, and supplier.

A CoA should not be treated as a substitute for checking supplier authorisation, manufacturing arrangements, and other required records.

2. Batch Manufacturing Record

This record documents the relevant manufacturing operations for a batch, including material usage, process stages, checks, and required approvals.

3. Batch Packaging Record

This record documents relevant packaging and labelling operations, including the materials used and required reconciliation or checks.

4. Standard Operating Procedures (SOPs)

SOPs provide approved instructions for performing specific activities consistently. Examples include sampling, laboratory testing, equipment cleaning, deviation handling, and document review.

5. Equipment calibration and qualification records

These records help demonstrate that relevant equipment and instruments are suitable for their intended use and are maintained or calibrated according to approved procedures.

6. Stability study records

Stability studies provide evidence about how a product’s quality changes over time under specified conditions. Such data help support shelf-life and storage-condition decisions.

7. Deviation and investigation records

These records document unexpected events, investigations, identified causes, and corrective or preventive actions, where applicable.

8. Product and manufacturing authorisation documents

The relevant licences, product permissions, technical agreements, and supporting records should be reviewed according to the product and business arrangement.

Document requirements can differ by product, facility, and applicable regulation. Businesses should not assume that every document listed above applies identically to every medicine.

Understanding GMP and Schedule M in India

Good Manufacturing Practices are designed to help ensure that pharmaceutical products are consistently manufactured and controlled according to the required quality standards.

In India, Schedule M of the Drugs Rules, 1945 sets out GMP requirements for pharmaceutical manufacturing. The revised Schedule M was notified through G.S.R. 922(E), dated 28 December 2023, with implementation timelines that differed by manufacturer category.

Companies should verify the current applicable provisions, any relevant extensions or transitional arrangements, and the requirements for their specific facility rather than relying on old checklists or general online summaries.

GMP is broader than laboratory testing. It includes relevant areas such as premises, equipment, personnel, sanitation, production controls, quality control, documentation, validation, complaint handling, and recall procedures.

A manufacturer or business procuring medicines should evaluate the applicable licence and GMP documentation rather than assuming that a general claim of quality certification proves compliance for every product or activity.

How Are Out-of-Specification Results Managed?

An out-of-specification (OOS) result is a test result that falls outside an established acceptance criterion.

Such a result requires a documented investigation under the applicable quality procedure. The investigation may assess laboratory operations, calculations, instruments, samples, test methods, manufacturing records, and other relevant factors.

A proper investigation should:

1. Record the original result and relevant information.
2. Assess whether a laboratory error or another assignable cause is supported by evidence.
3. Investigate manufacturing or material factors where appropriate.
4. Document the findings and rationale.
5. Determine the appropriate disposition of the batch.
6. Implement corrective or preventive actions when needed.

A result should not be dismissed without evidence. Any retesting, resampling, or additional investigation must follow the approved procedure and applicable requirements.

Common Pharmaceutical Quality Control Challenges

Pharmaceutical companies may face several challenges when maintaining quality systems.

Inconsistent raw material quality

Variability between material suppliers or deliveries can affect manufacturing. Supplier qualification, appropriate specifications, and incoming material controls help manage this risk.

Incomplete documentation

Missing entries, inconsistent records, or undocumented changes can make it difficult to establish what happened during production. Good documentation practices and timely record review help improve traceability.

Equipment and testing issues

Equipment that is unsuitable, poorly maintained, or outside its required calibration status can affect results. Appropriate qualification, calibration, maintenance, and investigation procedures are important.

Packaging and labelling errors

Incorrect labels, batch numbers, or printed materials can create serious product-identification risks. Controlled issuance, line clearance, verification, and reconciliation help reduce these errors.

Inadequate deviation investigation

A superficial investigation may fail to identify the underlying cause of a problem. A structured investigation should consider the potential impact on the product and whether similar batches or processes could be affected.

Weak oversight of outsourced manufacturing

When manufacturing or testing activities are outsourced, the relevant parties need clearly defined responsibilities and suitable oversight. Contracts and technical agreements should establish who is responsible for each quality activity.

How to Evaluate a Pharmaceutical Manufacturing Partner

For pharmaceutical distributors, franchise businesses, and companies seeking third-party manufacturing, the selection process should include more than price and product availability.

Consider these points:

• Regulatory documentation: Verify the relevant manufacturing licence, product permissions, and other applicable documents.
• Manufacturing arrangements: Understand which facility will manufacture and test the product.
• Quality systems: Ask about applicable GMP compliance, testing procedures, documentation, and deviation handling.
• Product specifications: Confirm the dosage form, strength, approved specifications, and required packaging details.
• Batch documentation: Establish which batch-related documents will be provided.
• Traceability: Understand how the supplier identifies batches and handles quality complaints or potential recalls.
• Storage and distribution: Confirm that handling conditions are suitable for the product.
• Commercial terms: Clarify minimum order quantities, lead times, payment terms, and responsibilities in writing.

Do not assume that a supplier’s website or a general certification statement is sufficient evidence for every product. Verify the relevant details for the actual manufacturing and supply arrangement.

Pharmaceutical Quality and Ernst Pharmacia

Ernst Pharmacia operates in the Indian pharmaceutical market and offers pharmaceutical products and third-party manufacturing-related services. Businesses interested in its offerings can review the company’s official website and contact its team to discuss product availability, manufacturing arrangements, and relevant documentation.

Before placing an order or entering a manufacturing agreement, buyers should confirm the specific product, manufacturing site, applicable licences and permissions, quality documentation, commercial terms, and responsibilities of each party.

Visit the official website: https://ernstpharmacia.com/

For product and manufacturing enquiries: https://ernstpharmacia.com/contact-us/

The applicable quality and regulatory requirements should be confirmed for each product and arrangement. No general statement about a company should replace verification of the relevant documents.

Best Practices for Maintaining Pharmaceutical Quality

Pharmaceutical companies can strengthen quality management by following a structured approach:

1. Maintain approved specifications and written procedures.
2. Use qualified suppliers and appropriate incoming-material controls.
3. Ensure personnel are trained for their assigned responsibilities.
4. Maintain equipment according to approved procedures.
5. Document manufacturing and testing activities accurately and promptly.
6. Review laboratory results and investigate unexpected findings.
7. Control changes to materials, methods, equipment, and processes.
8. Keep batch records complete, traceable, and appropriately reviewed.
9. Maintain suitable storage and transportation conditions.
10. Review complaints, deviations, and quality trends to identify opportunities for improvement.

These practices support a quality system in which prevention, documentation, investigation, and continual improvement work together.

Frequently Asked Questions

1. What is pharmaceutical quality control in India?

Pharmaceutical quality control in India involves sampling, testing, inspecting, and documenting materials and medicines to determine whether they meet established specifications and applicable regulatory requirements. It forms part of a wider pharmaceutical quality system.

2. What tests are performed on pharmaceutical products?

Tests depend on the product and its specifications. They may include identity, assay, purity, dissolution, uniformity, pH, microbial quality, sterility, or other tests where applicable. No single test list is suitable for every medicine.

3. What is the difference between quality control and quality assurance?

Quality control focuses on sampling, testing, results, and product evaluation. Quality assurance oversees the broader system of procedures, documentation, training, audits, deviation management, and other activities that help maintain consistent quality.

4. What is batch release in pharmaceutical manufacturing?

Batch release is the authorised decision that a particular batch meets applicable requirements for release. It generally involves reviewing manufacturing records, laboratory results, packaging records, deviations, and required approvals.

5. What is a Certificate of Analysis in pharmaceuticals?

A Certificate of Analysis (CoA) reports specified test results for a particular material or product batch. It should identify the relevant material or product and show results against applicable acceptance criteria.

6. What is GMP in the pharmaceutical industry?

Good Manufacturing Practices are requirements and systems intended to ensure that medicines are consistently manufactured and controlled to the required quality standards. GMP covers production, personnel, facilities, equipment, documentation, and quality control.

7. What is Schedule M in India?

Schedule M of India’s Drugs Rules, 1945 contains GMP requirements for pharmaceutical manufacturing. Companies should check the currently applicable provisions and implementation requirements for their facility and activities.

8. What happens if a medicine batch fails a quality test?

The result must be handled through the applicable investigation and quality procedure. The batch may remain on hold while the issue is investigated, and the documented findings determine the appropriate disposition. A failed result should not be ignored or overridden without a justified, documented basis.

9. Why is pharmaceutical documentation important?

Documentation provides traceable evidence of manufacturing operations, test results, reviews, and quality decisions. Accurate records support investigations, audits, regulatory review, and decisions about whether a batch can be released.

10. What should a buyer check before selecting a pharmaceutical manufacturer?

A buyer should verify relevant licences and product permissions, the manufacturing site, applicable quality documentation, testing arrangements, batch records, product specifications, storage and distribution practices, and written commercial terms.

Conclusion

Pharmaceutical quality control in India involves much more than testing a finished medicine. It requires appropriate controls for raw materials, manufacturing processes, packaging, laboratory testing, documentation, investigations, and authorised batch release.

For pharmaceutical companies and buyers, a structured approach to quality helps support consistency, traceability, and compliance with applicable requirements. Before selecting a supplier or manufacturing partner, businesses should verify the relevant documents and responsibilities for the specific product and facility.

Disclaimer: This article is for general pharmaceutical-industry information only. It is not a substitute for current regulatory guidance, product-specific specifications, or professional legal and quality-compliance advice.